{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:20:33Z","timestamp":1788481233162,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["VAME-2025-2"],"award-info":[{"award-number":["VAME-2025-2"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["252300421130"],"award-info":[{"award-number":["252300421130"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009101","name":"Education Department of Henan Province","doi-asserted-by":"publisher","award":["225200810116"],"award-info":[{"award-number":["225200810116"]}],"id":[{"id":"10.13039\/501100009101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["23A350009"],"award-info":[{"award-number":["23A350009"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["25B360021"],"award-info":[{"award-number":["25B360021"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["SBGJ202503046"],"award-info":[{"award-number":["SBGJ202503046"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["JQRC2025018"],"award-info":[{"award-number":["JQRC2025018"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109111","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:11:09Z","timestamp":1760998269000},"page":"109111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting FUT1-mediated EGFR fucosylation and COX-2 reverses gemcitabine resistance by activating immunogenic cell death in hepatocellular carcinoma"],"prefix":"10.1016","volume":"166","author":[{"given":"Na.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songshen","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng George","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2025.109111_bb0005","first-page":"394","article-title":"Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma","volume":"62","author":"Maluccio","year":"2012","journal-title":"CA Cancer J. Clin."},{"issue":"10360","key":"10.1016\/j.bioorg.2025.109111_bb0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-108-3-390","article-title":"NIH conference. Hepatocellular carcinoma","volume":"108","author":"Di Bisceglie","year":"1988","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109111_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2468-1253(16)30018-8","article-title":"Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"1","author":"Degasperi","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.109111_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijsu.2020.04.043","article-title":"Emerging biomarkers in HCC patients: Current status","volume":"82s","author":"Pinto Marques","year":"2020","journal-title":"Int. J. Surg."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","article-title":"Advances in the early diagnosis of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2020","journal-title":"Genes Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.bioorg.2025.109111_bb0035","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0040","first-page":"35","article-title":"Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy","volume":"17","author":"Han","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.bioorg.2025.109111_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120043","article-title":"Recent advances and prospects in gemcitabine drug delivery systems","volume":"592","author":"Paroha","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109111_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drup.2015.10.002","article-title":"Gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"23","author":"Binenbaum","year":"2015","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109111_bb0055","first-page":"C540","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109111_bb0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.gendis.2015.07.003","article-title":"Promising molecular mechanisms responsible for gemcitabine resistance in cancer","volume":"2","author":"Jia","year":"2015","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0065","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/s41467-020-19970-9","article-title":"Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death","volume":"11","author":"Hayashi","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109111_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15698\/cst2021.04.247","article-title":"Inhibitory DAMPs in immunogenic cell death and its clinical implications","volume":"5","author":"Hayashi","year":"2021","journal-title":"Cell Stress"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109111_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109111_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1541-7786.MCR-19-0741","article-title":"Combined Src\/EGFR inhibition targets STAT3 signaling and induces stromal remodeling to improve survival in pancreatic Cancer","volume":"18","author":"Dosch","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1078-0432.CCR-10-1670","article-title":"Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth","volume":"17","author":"Nagaraj","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1476-4598-12-104","article-title":"Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer","volume":"12","author":"Venkatasubbarao","year":"2013","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1078-0432.CCR-10-2925","article-title":"Response to combined molecular targeting: defining the role of P-STAT3","volume":"17","author":"Egloff","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0100","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1038\/s41467-022-33037-x","article-title":"An EGFR\/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms","volume":"13","author":"Yao","year":"2022","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109111_bb0105","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.7150\/ijbs.79126","article-title":"Mucin 4 confers gemcitabine resistance and an unfavorable prognosis in patients with cholangiocarcinoma via AKT activation","volume":"19","author":"Pan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109111_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143377","article-title":"Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma","volume":"131","author":"Loong","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0115","doi-asserted-by":"crossref","first-page":"17266","DOI":"10.1038\/s41598-019-53601-8","article-title":"Terminal fucose mediates progression of human cholangiocarcinoma through EGF\/EGFR activation and the Akt\/Erk signaling pathway","volume":"9","author":"Indramanee","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109111_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.58","article-title":"miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and \u03b11,3-fucosylated glycans","volume":"6","author":"Zheng","year":"2017","journal-title":"Oncogenesis"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0125","first-page":"833","article-title":"Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway","volume":"23","author":"Liu","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2025.109111_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41420-019-0145-y","article-title":"Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells","volume":"5","author":"Lai","year":"2019","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109111_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.243","article-title":"Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells","volume":"7","author":"Tan","year":"2016","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109111_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00894-021-04986-9","article-title":"Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study","volume":"27","author":"Motamedi","year":"2021","journal-title":"J. Mol. Model."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570178053765393","article-title":"Structure \/ Activity Relationship of Carba- and C-Fucopyranosides as Inhibitors of an α 1,6-Fucosyltransferase by Molecular Modeling and Kinetic Studies","volume":"2","author":"Calderon","year":"2005","journal-title":"Lett. Org. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109111_bb0150","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1039\/b317067e","article-title":"The design and synthesis of a selective inhibitor of fucosyltransferase VI","volume":"2","author":"Galan","year":"2004","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109111_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ab.2007.08.029","article-title":"A miniaturized high-throughput screening assay for fucosyltransferase VII","volume":"372","author":"Ahsen","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2025.109111_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105677","article-title":"Recent developments on 1,8-Naphthalimide moiety as potential target for anticancer agents","volume":"121","author":"Tandon","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2025.109111_bb0165","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.2174\/092986709789909576","article-title":"Overview of naphthalimide analogs as anticancer agents","volume":"16","author":"Lv","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109111_bb0170","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/tcr.201600134","article-title":"1,8-Naphthalimide: a potent DNA Intercalator and target for Cancer therapy","volume":"17","author":"Tandon","year":"2017","journal-title":"Chem. Rec."},{"key":"10.1016\/j.bioorg.2025.109111_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","article-title":"Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy","volume":"102","author":"Zhao","year":"2016","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109111_bb0180","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","article-title":"HSPA5 regulates Ferroptotic cell death in Cancer cells","volume":"77","author":"Zhu","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109111_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","article-title":"Trends in the approval of cancer therapies by the FDA in the twenty-first century","volume":"22","author":"Scott","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109111_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109111_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2021.06.015","article-title":"Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone","volume":"519","author":"Ge","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.109111_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113469","article-title":"A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent","volume":"221","author":"Ma","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:10:53Z","timestamp":1773807053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"alternative-id":["S0045206825009915"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109111","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting FUT1-mediated EGFR fucosylation and COX-2 reverses gemcitabine resistance by activating immunogenic cell death in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109111"}}